China Money Network
Login
Join

Matrix Leads $15M Series A1 Funding In Anti-Tumor Drug Firm QnQuality

  • October 28, 2019 — 17:57 CST

This Data Is Locked!

This area is available only to Subscribers.

QnQuality Pharmaceuticals Ltd., a Shanghai-based drug R&D company, announces on Monday that it has raised US$15 million in a series A1 funding round led by... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: